Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Obesity (Silver Spring, Md.)
|
September 26, 2009
Mice deficient in phosphofructokinase-M have greatly decreased fat stores
Lisa Getty-Kaushik, Jason C Viereck, Jessie M Goodman, et al.
The Journal of Investigative Dermatology
|
July 17, 1998
Melanocortin 1 receptor variants in an Irish population
R Smith, E Healy, S Siddiqui, et al.
Anticancer Research
|
August 12, 2009
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer
John N Flanagan, Shasha Zheng, Kun-Chun Chiang, et al.
Epigenetics
|
September 24, 2019
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes
Adrian E Boström, Andreas Chatzittofis, Diana-Maria Ciuculete, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 28, 2007
Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion
Ann-Marie T Richard, Dominic-Luc Webb, Jessie M Goodman, et al.
Molecular and Cellular Endocrinology
|
September 20, 2008
Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes
Vandana Gupta, Shalender Bhasin, Wen Guo, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 19, 2013
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase
Kun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Contemporary Clinical Trials Communications
|
July 20, 2018
Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study
Anna Wiik, Daniel P Andersson, Torkel B Brismar, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Obesity (Silver Spring, Md.)
|
September 26, 2009
Mice deficient in phosphofructokinase-M have greatly decreased fat stores
Lisa Getty-Kaushik, Jason C Viereck, Jessie M Goodman, et al.
The Journal of Investigative Dermatology
|
July 17, 1998
Melanocortin 1 receptor variants in an Irish population
R Smith, E Healy, S Siddiqui, et al.
Anticancer Research
|
August 12, 2009
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer
John N Flanagan, Shasha Zheng, Kun-Chun Chiang, et al.
Epigenetics
|
September 24, 2019
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes
Adrian E Boström, Andreas Chatzittofis, Diana-Maria Ciuculete, et al.
American Journal of Physiology. Endocrinology and Metabolism
|
June 28, 2007
Tissue-dependent loss of phosphofructokinase-M in mice with interrupted activity of the distal promoter: impairment in insulin secretion
Ann-Marie T Richard, Dominic-Luc Webb, Jessie M Goodman, et al.
Molecular and Cellular Endocrinology
|
September 20, 2008
Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes
Vandana Gupta, Shalender Bhasin, Wen Guo, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
September 19, 2013
MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase
Kun-Chun Chiang, Chun-Nan Yeh, Jun-Te Hsu, et al.
Contemporary Clinical Trials Communications
|
July 20, 2018
Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study
Anna Wiik, Daniel P Andersson, Torkel B Brismar, et al.
Page
of 6